FR1426M - 2-alcoyl-3-allylthiométhyl-7-sulfamyl-3,4-dihydrobenzo-1,1-dioxo-1-thia-2,4,-diazines substituées en position 6. - Google Patents

2-alcoyl-3-allylthiométhyl-7-sulfamyl-3,4-dihydrobenzo-1,1-dioxo-1-thia-2,4,-diazines substituées en position 6.

Info

Publication number
FR1426M
FR1426M FR867816A FR867816A FR1426M FR 1426 M FR1426 M FR 1426M FR 867816 A FR867816 A FR 867816A FR 867816 A FR867816 A FR 867816A FR 1426 M FR1426 M FR 1426M
Authority
FR
France
Prior art keywords
allylthiomethyl
diazines
sulfamyl
dihydrobenzo
thia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR867816A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Charles Pfizer and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc, Charles Pfizer and Co Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of FR1426M publication Critical patent/FR1426M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • C07D285/26—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
    • C07D285/30—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with hydrocarbon radicals, substituted by hetero atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04D—NON-POSITIVE-DISPLACEMENT PUMPS
    • F04D29/00—Details, component parts, or accessories
    • F04D29/08—Sealings
    • F04D29/10—Shaft sealings
    • F04D29/12—Shaft sealings using sealing-rings
    • F04D29/126—Shaft sealings using sealing-rings especially adapted for liquid pumps
    • F04D29/128—Shaft sealings using sealing-rings especially adapted for liquid pumps with special means for adducting cooling or sealing fluid
FR867816A 1960-09-27 1961-07-12 2-alcoyl-3-allylthiométhyl-7-sulfamyl-3,4-dihydrobenzo-1,1-dioxo-1-thia-2,4,-diazines substituées en position 6. Active FR1426M (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58632A US3102882A (en) 1960-09-27 1960-09-27 Derivatives of 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide
GB991/61A GB902658A (en) 1960-09-27 1961-01-10 6-substituted (or unsubstituted) 2-alkyl-3-allylthiomethyl-7-sulphamyl-3,4-dihydrobenzothiadiazine dioxides and process for preparation

Publications (1)

Publication Number Publication Date
FR1426M true FR1426M (fr) 1962-08-06

Family

ID=26236340

Family Applications (1)

Application Number Title Priority Date Filing Date
FR867816A Active FR1426M (fr) 1960-09-27 1961-07-12 2-alcoyl-3-allylthiométhyl-7-sulfamyl-3,4-dihydrobenzo-1,1-dioxo-1-thia-2,4,-diazines substituées en position 6.

Country Status (6)

Country Link
US (1) US3102882A (US07235543-20070626-C00056.png)
BE (1) BE606063A (US07235543-20070626-C00056.png)
DE (2) DE1445121A1 (US07235543-20070626-C00056.png)
ES (1) ES270748A1 (US07235543-20070626-C00056.png)
FR (1) FR1426M (US07235543-20070626-C00056.png)
GB (2) GB902658A (US07235543-20070626-C00056.png)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265573A (en) * 1962-07-27 1966-08-09 Squibb & Sons Inc Benzothiadiazinesulfonamide-1, 1-dioxide composition
US3251837A (en) * 1962-09-14 1966-05-17 Pfizer & Co C Derivatives of 1, 2, 4-benzothiadiazine-1, 1-dioxides
US4338435A (en) * 1981-06-01 1982-07-06 E. R. Squibb & Sons, Inc. Benzothiadiazines having diuretic activity
RS20050106A (en) 2002-08-19 2007-11-15 Pfizer Products Inc., Combination therapy for hyperproliferative diseases
ATE406364T1 (de) 2003-03-07 2008-09-15 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
CN1756756A (zh) 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2009149279A2 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CA2913737A1 (en) 2013-06-05 2014-12-11 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase c, method of making and using same
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Also Published As

Publication number Publication date
GB905137A (en) 1962-09-05
US3102882A (en) 1963-09-03
ES270748A1 (es) 1961-12-16
BE606063A (fr) 1962-01-12
DE1445121A1 (de) 1968-11-28
GB902658A (en) 1962-08-09
DE1302648B (US07235543-20070626-C00056.png)

Similar Documents

Publication Publication Date Title
FR1426M (fr) 2-alcoyl-3-allylthiométhyl-7-sulfamyl-3,4-dihydrobenzo-1,1-dioxo-1-thia-2,4,-diazines substituées en position 6.
FR1417M (fr) 2-cyano-3-oxo-stéroides.
FR1376M (fr) Hydrindene-sulfonylurées.
DK104277C (da) Termokopieringsmaskine.
FR1165M (fr) α-pyrrolidino-acétophénones.
FR1683M (fr) Gem-difluorostéroides.
FR1545M (fr) 11-oxygéno-progestérone-3,20-dioximes.
DK97274C (da) Murbor.
FR1566M (fr) 6α-16-méthylene-stéroides.
FR1290M (fr) 2-cyanostéroides.
FR1697M (fr) 17 β-hydroxy-17 α-méthyl-2-oxa-3-oxo-5 α-androstane.
FR1321M (fr) 3,20-bisoximes de prégnanes.
FR1482M (fr) La n-p-toluene-sulfonyl-n-beta-méthylsulfinyléthyl-urée.
IS1142A7 (is) 7 o.s.frv. 11a - Halogen - o.s.frv. 7, 11 a - Dihalogen - 6 desoxytetracyclin.
FR1282M (fr) Sulfapyrimidines.
DK97159C (da) Plov.
FR1442M (fr) Sulfapyrimidines.
FR1440M (fr) Sulfapyrimidines.
BE600923R (fr) Diazotypmateriaal.
BE595201R (fr) Binnenscheepvaartschroef.
FR1319M (fr) Stéroide-3-énolacylés.
BE589995R (fr) Elektrofotografisch materiaal.
BE589994R (fr) Elektrofotografisch materiaal.
FR1167M (fr) α-pyrrolidino-propio-phénones.
BE598039R (fr) Bodeminjectieapparaat.